Optical biomodule for detection of diseases at an early onset

Patent metadata

Field	Value
Publication number	US-10529003-B2
Application number	US-201715731577-A
Country	US
Kind code	B2
Filing date	Jul 3, 2017
Priority date	Apr 7, 2008
Publication date	Jan 7, 2020
Grant date	Jan 7, 2020

Abstract

An optical biomodule for detecting a disease specific biomarker(s), utilizing enhanced fluorescence emission (due to integration of a three-dimensional (3-D) protruded structure (s)) in a fluidic container/zero-mode waveguide, upon chemical binding of a disease specific biomarker(s) with its corresponding disease specific biomarker binder(s) (e.g., an aptamer(s)) is disclosed.

First claim

I claim:

1. An optical biomodule comprises:
(a) a fluidic container;
wherein a substrate of the fluidic container comprises: one or more materials,
wherein the fluidic container comprises: a first biomarker binder or a second biomarker binder,
wherein the first biomarker binder is coupled with a first fluorophore or a first photoswitchable fluorophore,

wherein the fluidic container comprises: one or more three-dimensional (3-D) protruded structures,
wherein the first fluorophore or the first photoswitchable fluorophore is positioned horizontally relative to an open space of the one three-dimensional (3-D) protruded structure
or
the second biomarker binder is positioned horizontally relative to the open space of the one three-dimensional (3-D) protruded structure,

wherein a dimension or shape of the one three-dimensional (3-D) protruded structure is varied for maximum enhancement of fluorescence emission,
wherein more than the one three-dimensional (3-D) protruded structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a gap or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) protruded structures is varied for maximum enhancement of the fluorescence emission;

(b) a light source or light sources directed at the fluidic container for inducing the fluorescence emission due to an interaction of the first biomarker binder or the second biomarker binder with a biomarker; and
(c) a device for detecting the fluorescence emission from the fluidic container.

2. The optical biomodule according to claim 1 , wherein the substrate of the fluidic container comprises: a periodic layers of one or more materials.

3. The optical biomodule according to claim 1 , wherein the first biomarker binder is selected from the group consisting of: an isolated antibody, a synthetically designed antibody, an aptamer, a wavelength-shifting aptamer and a synthetically designed protein, wherein the synthetically designed protein has a binding site to bind with the biomarker.

4. The optical biomodule according to claim 1 , wherein the first biomarker binder is a nano-scaled synthetically designed biomolecular circuit, wherein the nano-scaled synthetically designed biomolecular circuit comprises: (i) a synthetically designed riboswitch or (ii) a DNA sequence of adenine (A), thymine (T), guanine (G) and cytosine (C) or (iii) a DNA sequence of adenine (A), thymine (T), guanine, (G) cytosine (C) and a synthetically designed molecule or (iv) an RNA sequence or (v) a programmable synthetically designed DNA-targeting-cleaving enzyme or (vi) a programmable synthetically designed RNA-targeting-cleaving enzyme.

5. The optical biomodule according to claim 4 , wherein the nano-scaled synthetically designed biomolecular circuit further comprises: a synthetically designed biological logic circuit.

6. The optical biomodule according to claim 1 , wherein the first biomarker binder comprises: a nanoshell, wherein the nanoshell is decorated with a cleavable biological material, wherein the cleavable biological material is cleaved from a diseased cell or a decorated diseased cell.

7. The optical biomodule according to claim 1 , wherein the first biomarker binder comprises: a synthetically designed exosome-specific biomarker binder to couple with a molecule of an exosome.

8. The optical biomodule according to claim 1 , wherein the second biomarker binder comprises: an aptamer beacon or a molecular beacon or a noble metal atom nanocluster beacon or a synthetically designed riboswitch beacon.

9. The optical biomodule according to claim 8 , wherein the aptamer beacon or the molecular beacon or the noble metal atom nanocluster beacon or the synthetically designed riboswitch beacon comprises: a synthetically designed biological logic circuit.

10. The optical biomodule according to claim 1 , wherein the second biomarker binder is coupled with a nanostructural element or the second biomarker binder is coupled with a point defect of the nanostructural element.

11. The optical biomodule according to claim 10 , wherein the nanostructural element is electrically conducting, wherein the nanostructural element is electrically activated or electrically coupled with a field effect transistor.

12. The optical biomodule according to claim 1 , wherein the second biomarker binder comprises: an aptamer sensor, wherein the aptamer sensor comprises: a first chemical segment to couple with the biomarker and a second chemical segment to couple with a second fluorophore or a second photoswitchable fluorophore.

13. The optical biomodule according to claim 1 , wherein the second biomarker binder comprises: a first isolated antibody and a second isolated antibody, wherein the first isolated antibody or the second isolated antibody is coupled with a second fluorophore or a second photoswitchable fluorophore.

14. The optical biomodule according to claim 1 , wherein the second biomarker binder comprises: a first synthetically designed antibody and a second synthetically designed antibody, wherein the first synthetically designed antibody or the second synthetically designed antibody is coupled with a second fluorophore or a second photoswitchable fluorophore.

15. The optical biomodule according to claim 14 , wherein the first synthetically designed antibody or the second synthetically designed antibody is arranged in three-dimension (3-D).

16. The optical biomodule according to claim 1 , wherein the one three-dimensional (3-D) protruded structure is an optical nanoantenna or a three-dimensional (3-D) protruded structure of a two-dimensional (2-D) material or a conducting nanotube or a sharp tip or a hyperbolic metamaterial surface.

17. The optical biomodule according to claim 16 , wherein the optical nanoantenna comprises: a room temperature stable topological insulator or a two-dimensional (2-D) material or a nanoparticle.

18. The optical biomodule according to claim 16 , wherein the hyperbolic metamaterial surface comprises: nanoholes or gratings.

19. The optical biomodule according to claim 1 , wherein the light source of the particular wavelength or the light sources of the distinct wavelengths comprises: a two-dimensional (2-D) material.

20. The optical biomodule according to claim 1 , wherein the light sources comprise: a first coherent light source and a second coherent light source, wherein a beam of the first coherent light source is approximately an open toroidal shaped, wherein the first coherent light source and the second coherent light source are activated simultaneously.

21. The optical biomodule according to claim 1 , comprises: an abruptly constricted fluid container, wherein a maximum dimension of the abruptly constricted fluid container is less than a maximum dimension of a cell or a stem cell or a T cell.

22. The optical biomodule according to claim 1 , comprises: a device to isolate exosomes from a biological fluid and to isolate molecules from the exosomes, wherein the device comprises: a separator module to isolate exosomes-attached magnetic beads or a nano-scaled filter to filter the exosome from the biological fluid.

23. An optical biomodule comprises:
(a) a fluidic container;
wherein a substrate of the fluidic container comprises: one or more materials,
wherein the fluidic container comprises: a first biomarker binder or a second biomarker binder,
wherein the first biomarker bin

Assignees

• Mazed Mohammad A

Inventors

• Mazed Mohammad A

Classifications

• G06Q20/223

  based on the use of peer-to-peer networks · CPC title

• G06Q20/065

  using e-cash · CPC title

• A61B2090/365

  augmented reality, i.e. correlating a live optical image with another image · CPC title

• B82Y5/00

  Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

• G10L15/00

  Speech recognition (G10L17/00 takes precedence) · CPC title